📣 Calling all BioFlorida, Inc. Members - Exclusive opportunity to connect with Florida's Senator Rick Scott! To further our commitment of providing value-added programing, we are excited to announce a unique opportunity for BioFlorida members to participate in a webinar with United States Senate Rick Scott. During this event, we aim to address the most pressing considerations within #Florida's life science ecosystem. BioFlorida members are encouraged to submit questions beforehand, and Senator Scott will address as many as possible during the session. This event will offer valuable insights into critical elements affecting Florida's life science industry and the wider business community. Event Details: ▫ Date: July 25, 2024 ▫ Time: 12:00 pm - 12:30 EDT ▫ Platform: Zoom link to be provided upon registration ❓ Submit a question - https://lnkd.in/dybXm75X ➡ Register to attend - https://lnkd.in/dFqyaeZp HOSTED IN PARTNERSHIP WITH METZ HUSBAND & DAUGHTON, PA About BioFlorida, Inc.: BioFlorida is the life sciences trade association for Florida, representing BioPharma, MedTech, Digital Health and Health Systems, and aligning industries. Our value-based membership supports the industry through: 👀 Visibility ℹ Industry Insights, Education & Information 🤝 Networking & Events 💲 Cost Savings 📜 Policy & Advocacy 📈 Capital & Growth To inquire about #membership opportunities, please connect with us at: bioflorida.com, admin@bioflorida.com, or 561-653-3839 Mark Glickman, Lorrie Albinson, MBA, Tara Ann Coleman, MBA, Ian Leventhal
BioFlorida, Inc.’s Post
More Relevant Posts
-
What an experience at the BIO International Convention in San Diego this past week. Our CEO, Zach Gobst, shared some powerful insights on why APAC is a prime destination for complex and challenging clinical trials. One key insight: “Designing recruitment around engagement is crucial. In APAC, you can work with patients and physicians who prioritize your research, paired with a local staff model to navigate study nuances for high-quality results.” Tailoring our approach at the country and local level is a key element of Leapcure’s approach. It ensures better study outcomes and a deeper connection with the broader community. Let’s all continue to innovate and make a global impact. #clinicaltrials #APAC #patientengagement #BIO2024 #leapcure
To view or add a comment, sign in
-
🚀 Elevate Your Brand at BIO Europe 🌍 Are you ready to showcase your innovation to the world? 📈 The BIO Europe conference is a great stage for life science leaders, and One Nucleus is preparing the ON Helix Review for release at the conference. This could be the spotlight your company needs to shine brighter at BIO Europe and beyond. Prices start at just £500 + VAT for One Nucleus members. Why Sponsor the ON Helix Review? ✨ Unparalleled Visibility: Reach thousands of top-tier professionals and decision-makers in the international life sciences. ✨ Targeted Audience: Connect directly with your ideal customers, investors, and partners. ✨ Premium Placement: Stand out in a comprehensive review that attendees trust and reference. 📅 Don’t miss this golden opportunity to amplify your brand’s impact at one of the most influential events of the year. Secure your ad space now and be part of the conversation driving the future of life sciences. 🌟 Join us in transforming the future of life sciences and biotechnology. Your innovation deserves the spotlight! 🔗 Find out more here https://lnkd.in/eJ-TwrdB #BIOEurope #LifeSciences #Biotech #Innovation #Healthcare #BusinessGrowth #Marketing #Conference2024
To view or add a comment, sign in
-
⭕ Round table during #Horizon4Poland 2023 - The largest matchmaking event in the R&D sector in Poland 📅 Coming on November 2️⃣ 1️⃣ st 📍 Fabryka Norblina 👆 We'll discuss about IHI program - including public private partnership perspective. An open discussion led by Magdalena Kulczycka,Ph.D., Director of Central European BioForum, and Magali Poinot Team Leader of the Governance Cell at Innovative Health Initiative (IHI), will help answer questions such as: ✅ What SMEs need from the IHI program? ✅ What obstacles do they have when applying to programs? ✅ What are the benefits for SMEs ? ✅ How big pharma companies see the benefits from IHI programs - for them/ for the ecosystem? ✅ How IHI programs can stimulate the biotech ecosystem ? ✅ How IHI programs stimulate the European ecosystem on a global scale? Interested ❓ Join us during the event ➡ https://lnkd.in/dkbRP5Kv Anna Kacprzyk, Monika Ślęzak, Katarzyna Banyś, Igor Deryło #HoryzontEuropa, #science, #business, #cooperation
To view or add a comment, sign in
-
How to make academic #digitalhealth excellence in in #Berlin and #Brandenburg sustainable? What specific incentives are required to attract innovative #pharma and #lifescience companies to invest in Germany‘s capital region is discussed on stage of the 2024 forum on healthcare industry by Verlag Der Tagesspiegel.
To view or add a comment, sign in
-
[#innaxe4eu] Zoom on insights from the Council of European BioRegions - CEBR! 🛠️ Last month, Council of European BioRegions - CEBR organized interviews and an interactive discussion on “Enhancing the impact of EU life sciences clusters actions through international cooperation” with stakeholders from the health and life science European sector to gather insights and recommendations on INNAXE’s future joint action plan. 📌 Cluster to cluster (C2C) cooperation is pivotal, grounded in mutual trust and involving cluster organizations, their companies, and stakeholders directly. 📌 EU clusters are motivated to collaborate in tackling shared challenges, demonstrating a collective commitment to innovation. 📌 Matching innovators with investors poses a significant challenge across diverse countries and ecosystems, emphasized as a top priority for many clusters. 📌 Real-world needs should inform the development of new products, with public procurement of innovation playing a role in enhancing healthcare quality and equity. 📌 European cooperation prioritizes advanced therapies and health data access, with regulatory and educational aspects taking precedence over technical considerations. Additionally, cascade funding is recognized as a valuable tool to support competitiveness, underscored by the importance of quality support provided by clusters. 🙏 Many thanks to Council of European BioRegions - CEBR BioRegions and the European ecosystem for their shared insights to consolidate our joint action plan. #innaxe4eu #Europe #innovation #health #clusters #lifescience #biotech #medtech Marta González Anaïs Le Corvec Alberto Baldi
To view or add a comment, sign in
-
Piper Alderman Partner | NED | Life Sciences & Healthcare | Refreshingly practical advice for innovative organisations | Corporate Governance | M & A | Capital Raising | Collaborations | GAICD | FGIA
At AusBiotech #ausbiotech2023 a panel of Patricia Vietheer, PhD Chris Smith Professor John Skerritt, The Hon Gabrielle Upton FAICD FRSN Dr Alan Taylor Bruce Goodwin consider the path to commercial viability: ↗️ meeting a clear unmet need ↗️ having a strong and committed team ↗️ making an assessment on whether your tech will be competitive 7 - 10 years from now 💰contemplating the cost of developing a successful drug — USD 6.7m including the costs of failure along the way 💰 thinking about pricing and reimbursement and the related health technology assessments, and designing your clinical program to generate the relevant data 💡understanding how your IP interacts with the broader IP landscape 💡 ensuring that you generate “regulatory-grade” data 🏭 get your CMC right! 🤝 nurture your shareholder relationships ➕ our R & D incentive is invaluable! 🏹 target your communications to government — help them understand how your project will benefit the community (i.e create jobs). A thesis isn’t a pitch! 🌉 government isn’t the best at helping companies know who to talk with 🦘 Australia is a friendly ecosystem — people are generous with sharing expertise and learnings 🔃 you need to be adaptable because the environment keeps changing
To view or add a comment, sign in
-
Scientific Publication services for doctors and Industry I Medical communication Expert I Entrepreneur I Hatha yoga teacher
Are you a forward-thinking #biotech or #pharma company on the hunt for funds to fuel your innovative projects? Look no further! At Turacoz Healthcare Solutions, we understand the challenges and opportunities in the ever-evolving landscape of biotechnology and pharmaceuticals. We are excited to announce that we'll be at #BioEurope in #Munich, and we invite you to connect with us. Our team specializes in providing comprehensive support for companies like yours. Here's how we can help you make a compelling case to potential investors: Competitive Intelligence: In today's competitive market, staying ahead is crucial. We offer in-depth competitive intelligence to help you understand your market better, identify key players, and position your company for success. Funding Proposal Writing: Crafting a persuasive funding proposal is an art, and we've mastered it. Our experienced team can assist you in creating a compelling proposal that showcases your company's potential and aligns with the expectations of investors. Clinical Evaluation Plan: Investors want to see a well-thought-out plan for your clinical trials. We can help you develop a robust clinical evaluation plan that not only meets regulatory requirements but also appeals to potential backers. Join us at #BioEurope in #Munich, and let's discuss how Turacoz Healthcare Solutions can be your strategic partner on your funding journey. Don't miss out on this opportunity to tap into our expertise and take your biotech or pharma venture to the next level. Connect with us today, and let's explore the possibilities together! #BiotechFunding #PharmaFunding #BiotechInvestment #PharmaInvestment #InnovationInHealthcare #TuracozHealthcareSolutions
Scientific Publication services for doctors and Industry I Medical communication Expert I Entrepreneur I Hatha yoga teacher
I'm excited to attend BIO-Europe 2023 and representing Turacoz Group Turacoz Healthcare Solutions - A Medical Communications Company along with Dr Namrata singh from November 6–8, 2023 in Munich. Join me to meet one-to-one! https://lnkd.in/d2NbW9xT . Informa Connect
To view or add a comment, sign in
-
We are thrilled to invite you to "Life Sciences - In Focus: Navigating the Regulatory Landscape – Latin America Edition," featuring our esteemed CEO, Sara Tylosky, and Maria Mateos from Vistatec Life Sciences on June 27 at 4 pm GMT+1 / 5 pm CT / 8 am PT. Join us for an in-depth exploration of the regulatory requirements across key Latin American countries. We'll cover crucial timelines, strategies to expedite approvals, and ways to avoid common pitfalls. Discover the latest regulatory updates and trends and learn from real-world case studies and success stories. Whether you're currently working in Latin America or considering expanding your clinical research efforts there, this discussion is a must-attend! 🔗 Register Here: https://lnkd.in/eK-F45rM Don't miss this opportunity to gain valuable insights and connect with industry leaders. We look forward to seeing you there! #LifeSciences #ClinicalResearch #LatinAmerica #RegulatoryAffairs #Pharma #Biotech
Life Sciences - In Focus: Navigating the Regulatory Landscape – Latin America Edition https://lnkd.in/eK-F45rM Join us for this engaging panel discussion featuring esteemed guest speaker Sara Tylosky, MBA, CEO of Farmacon Global in discussion with Maria Mateos, Vistatec Life Sciences. June 27, 4 pm (GMT+1) | 5 pm (CET) | 8 am (PDT) This event will offer an in-depth look at the regulatory requirements across key Latin American countries, including crucial timelines and strategies to expedite approvals while avoiding common pitfalls. Discover the latest regulatory updates and trends as we explore their clinical research and development implications. Through case studies and real-world examples, learn from success stories and lessons gained from navigating the complex regulatory environment in Latin America. #LifeSciences #Vistatec
To view or add a comment, sign in
-
🌟 **Day 1 for Innova Solutions at the DIA Global Annual Event in San Diego!** 🌟 What an incredible start to the DIA Global Annual Event here in sunny San Diego! The energy and enthusiasm were palpable as we kicked off with insightful keynotes, engaging panel discussions, and dynamic networking opportunities. **Highlights from Day 1:** 🔹 **Opening Keynote:** Visionary insights on the future of healthcare and innovation. A powerful message about the importance of collaboration in driving progress. 🔹 **Panel Discussions:** Thought-provoking sessions on topics such as digital transformation in clinical trials, regulatory challenges, and patient-centric drug development. The experts brought diverse perspectives that sparked meaningful conversations. 🔹 **Innovation Hub:** The exhibit hall was buzzing with cutting-edge solutions and technologies. It was great to see the latest advancements in pharma and biotech up close and personal. Gen AI/ML has been the key topics in the technology space of participating organizations. 🔹 **Networking:** Connecting with industry leaders, peers, and new contacts was a highlight. The networking opportunities have been invaluable for exchanging ideas and forging new partnerships. Looking forward to the next few days of learning, sharing, and growing together. Stay tuned for more updates! DIA #DIA2024 #HealthcareInnovation #Pharma #Biotech #SanDiego #InnovaSolutions #LifeScineces
To view or add a comment, sign in
-
Key takeaways from LSX The LSX Nordic Congress is over after two inspiring days here in Copenhagen. While the current funding situation remains tough, we are leaving the congress with an optimistic view on the Nordic life science ecosystem. Here are our key takeaways from the congress: 💰 Funding challenges persist: The congress highlighted the ongoing difficulty in securing funding for biotech ventures. The heydays of 2020/21 are unlikely to return anytime soon. Biotech companies should prioritize strategies to extend their financial runways, streamline research programs, and maintain flexibility with both a Plan A and a Plan B. 📢 Value communication matters: While Nordic biotech companies excel in scientific innovation, many must improve their ability to convey the value of their research. Early communication of commercial value, gaps in standard of care, access pathways, and perspectives from patients, healthcare professionals, and key opinion leaders should be emphasized early in the development process. Focus on benefits, not features. 🔬 Focus on platform applications: Platform-based biotech companies should consider concentrating their efforts on one or a few select use cases that offer clear commercial potential, allowing for effective resource allocation and better foresight for investors. 🌍 Build global companies: Management teams within Nordic biotech companies should adopt a more international and diverse approach without losing their core strengths (quality of science, resilience, humbleness). This better positions Nordic biotechs to seize opportunities in the global market. Biobridge Partners remains dedicated to support the Nordic life science ecosystem and we look forward to continuing the productive dialogues initiated during the event. #LSXNordic #lifesciences #biobridgepartners
To view or add a comment, sign in
23,971 followers